Mark E Meyerhoff Selected Research

S-Nitroso-N-Acetylpenicillamine

3/2017	Reduction of Thrombosis and Bacterial Infection via Controlled Nitric Oxide (NO) Release from S-Nitroso-N-acetylpenicillamine (SNAP) Impregnated CarboSil Intravascular Catheters.
6/2015	S-Nitroso-N-acetylpenicillamine (SNAP) Impregnated Silicone Foley Catheters: A Potential Biomaterial/Device To Prevent Catheter-Associated Urinary Tract Infections.
1/2015	Reduction in Thrombosis and Bacterial Adhesion with 7 Day Implantation of S-Nitroso-N-acetylpenicillamine (SNAP)-Doped Elast-eon E2As Catheters in Sheep.
11/2013	The mediation of platelet quiescence by NO-releasing polymers via cGMP-induced serine 239 phosphorylation of vasodilator-stimulated phosphoprotein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark E Meyerhoff Research Topics

Disease

26	Thrombosis (Thrombus) 01/2021 - 10/2004
11	Infections 09/2019 - 01/2015
4	Bacterial Infections (Bacterial Infection) 03/2017 - 10/2014
3	Inflammation (Inflammations) 04/2020 - 12/2005
3	Wounds and Injuries (Trauma) 01/2019 - 10/2014
2	Urinary Tract Infections (Urinary Tract Infection) 01/2022 - 06/2015
2	Sepsis (Septicemia) 10/2020 - 10/2015
2	Hemorrhage 01/2020 - 05/2007
2	Critical Illness (Critically Ill) 05/2008 - 05/2007
2	Reperfusion Injury 11/2005 - 02/2004
1	Respiratory Tract Diseases (Respiratory Tract Disease) 08/2018
1	Foreign Bodies (Foreign Body) 12/2017
1	Catheter-Related Infections 01/2016
1	Rhinosinusitis 07/2015
1	Cicatrix (Scar) 10/2014
1	Burns 10/2014
1	Hemolysis 07/2009
1	Hypertension (High Blood Pressure) 07/2009
1	Suppuration 03/2006
1	Stroke (Strokes) 11/2005
1	Myocardial Infarction 11/2005
1	Hyperplasia 05/2005

Drug/Important Bio-Agent (IBA)

12	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 10/2004
9	PolymersIBA 06/2017 - 05/2005
4	S-Nitroso-N-AcetylpenicillamineIBA 03/2017 - 11/2013
3	Biocompatible Materials (Biomaterials)IBA 01/2019 - 06/2015
3	Polyurethanes (Polyurethane)IBA 01/2019 - 03/2006
2	Proteins (Proteins, Gene)FDA Link 04/2020 - 12/2005
2	Biological ProductsIBA 03/2016 - 02/2004
2	Peptides (Polypeptides)IBA 07/2015 - 02/2004
2	Glucose (Dextrose)FDA LinkGeneric 07/2011 - 05/2008
1	Molecular Probes (Molecular Probe)IBA 01/2022
1	Carbon DioxideIBA 10/2020
1	Complement System Proteins (Complement)IBA 04/2020
1	AnticoagulantsIBA 01/2020
1	DiaminesIBA 01/2020
1	Heparin (Liquaemin)FDA LinkGeneric 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	NitritesIBA 08/2018
1	IonsIBA 08/2018
1	LigandsIBA 08/2018
1	SolutionsIBA 10/2016
1	Silicone Elastomers (SE 30)IBA 01/2016
1	Anti-Infective Agents (Microbicides)IBA 01/2016
1	A 7 (A-7)IBA 10/2015
1	Protamines (Protamine Sulfate)FDA Link 07/2015
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 07/2015
1	SiliconesIBA 06/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2014
1	PotassiumIBA 07/2009
1	SodiumIBA 07/2009
1	GasesIBA 05/2008
1	ElectrolytesIBA 05/2008
1	AntithrombinsIBA 05/2007
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2007
1	O-desulfated heparinIBA 11/2005
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 11/2005
1	salicylhydroxamic acid (SHAM)IBA 10/2004
1	Biopolymers (Biopolymer)IBA 10/2004
1	Phenobarbital (Luminal)FDA Link 10/2004
1	FibrinIBA 10/2004

Therapy/Procedure

17	Catheters 10/2020 - 01/2007
3	Urinary Catheters 01/2022 - 08/2015
3	Therapeutics 08/2018 - 09/2006
2	Renal Dialysis (Hemodialysis) 10/2020 - 09/2006
2	Extracorporeal Circulation 01/2016 - 05/2007
1	Transcranial Direct Current Stimulation 10/2020
1	Extracorporeal Membrane Oxygenation 01/2020
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2020
1	Central Venous Catheters 10/2016
1	Electrodes (Electrode) 07/2009